Takeda May Take Generic Path In South America, CEO Says
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Takeda Pharmaceutical will not be seeking the generic strategy Pfizer plans in Japan, but may make a generic plunge in South America, says the top executive of the largest Japanese pharma